Key Factors Affecting the Reproducibility of Synthesis and Growth Mechanism of Near-Infrared Absorbing Hollow Gold Nanospheres
Source abstract
Abstract
Hollow gold nanospheres (HGNs) with near-infrared (NIR) surface plasmon resonance (SPR) absorption are highly desired for many applications including photothermal ablation therapy (PTA) of cancer; however, they are challenging to synthesize at relevant resonant wavelengths in a reproducible manner. In this work, we have systematically varied the reaction parameters to determine the origin of the irreproducibility of synthesis. This allows for much finer control of the synthesis, including homogeneous NIR absorbing HGNs that were characterized using UV–vis spectroscopy and electron microscopy (EM) techniques. We have found that cobalt seed particle growth time plays a more critical role than previously realized and is one of the most important parameters for high synthetic reproducibility. The results also provide new insight into the mechanism of cobalt seed and HGN growth, which further aids the successful synthesis of high quality HGNs with strong and tunable NIR SPR absorption.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Nanoplatforms for cancer theranostics · Plasmonic and Surface Plasmon Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, United States
Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
Funding
National Science Foundation · Basic Energy Sciences · Delta Dental Plans Association
References (52)
Show source-provided references
1. Schwartzberg A. · J. Phys. Chem. C · 2008 · 112 · 1032310.1021/jp801770w ↗
2. Wang X. · J. Am. Chem. Soc. · 2012 · 134 · 741410.1021/ja300140c ↗
3. Young J. · Ann. Biomed. Eng. · 2012 · 40 · 43810.1007/s10439-011-0472-5 ↗
4. Sperling R. · Chem. Soc. Rev. · 2008 · 37 · 189610.1039/b712170a ↗
5. Lu W. · Clin. Cancer Res. · 2009 · 15 · 87610.1158/1078-0432.CCR-08-1480 ↗
6. Lu W. · Cancer Res. · 2010 · 70 · 317710.1158/0008-5472.CAN-09-3379 ↗
7. Melancon M. · Mol. Cancer Ther. · 2008 · 7 · 173010.1158/1535-7163.MCT-08-0016 ↗
8. Myroshnychenko V. · Chem. Soc. Rev. · 2008 · 37 · 179210.1039/b711486a ↗
9. Everts M. · Nano Lett. · 2006 · 6 · 58710.1021/nl0500555 ↗
10. Lu, W.; Tian, M.Drug Delivery Applications of Noninvasive Imaging: Validation from Biodistribution to Sites of Action;John Wiley & Sons, Inc.:Hoboken, NJ, 2013; pp308–332.10.1002/9781118356845.ch14 ↗
11. Liang H. · J. Phys. Chem.B · 2005 · 109 · 779510.1021/jp045006f ↗
12. Hirsch L. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 1354910.1073/pnas.2232479100 ↗
13. Hirsch L. · Ann. Biomed. Eng. · 2006 · 34 · 1510.1007/s10439-005-9001-8 ↗
14. Lowery A. · Int. J. Nanomed. · 2006 · 1 · 14910.2147/nano.2006.1.2.149 ↗
15. Jain P. · Acc. Chem. Res. · 2008 · 41 · 184210.1021/ar7002804 ↗
16. Dickerson E. · Cancer Lett. · 2008 · 269 · 5710.1016/j.canlet.2008.04.026 ↗
17. Goodrich G. · J. Biomed. Opt. · 2010 · 15 · 01800110.1117/1.3290817 ↗
18. Gobin A. · Int. J. Nanomed. · 2008 · 3 · 351
19. Melancon M. · ACS Nano · 2014 · 8 · 453010.1021/nn406632u ↗
20. Chithranit B. · Nano Lett. · 2006 · 6 · 66210.1021/nl052396o ↗
21. El-Sayed M. · Acc. Chem. Res. · 2004 · 37 · 32610.1021/ar020204f ↗
22. Parab H. · J. Phys. Chem. C · 2009 · 113 · 757410.1021/jp9000169 ↗
23. Akilany A. · J. Nanopart. Res. · 2010 · 12 · 231310.1007/s11051-010-9911-8 ↗
24. Zhang J. · J. Phys. Chem. Lett. · 2010 · 1 · 68610.1021/jz900366c ↗
25. Chen J. · Small · 2010 · 6 · 81110.1002/smll.200902216 ↗
26. Sun Y. · Adv. Mater. · 2003 · 15 · 64110.1002/adma.200301639 ↗
27. von Maltzahn G. · Cancer Res. · 2009 · 69 · 389210.1158/0008-5472.CAN-08-4242 ↗
28. Yuan H. · Nanomed. Nanotechnol. Bio. Med. · 2012 · 8 · 135510.1016/j.nano.2012.02.005 ↗
29. Huang X. · Lasers Med. Sci. · 2008 · 23 · 21710.1007/s10103-007-0470-x ↗
30. Melancon M. · Mol. Cancer Ther. · 2008 · 7 · 173010.1158/1535-7163.MCT-08-0016 ↗
31. Zharov V. · Lasers Surg. Med. · 2005 · 37 · 21910.1002/lsm.20223 ↗
32. Jain P. · Acc. Chem. Res. · 2008 · 41 · 157810.1021/ar7002804 ↗
33. Nam J. · J. Am. Chem. Soc. · 2009 · 131 · 1363910.1021/ja902062j ↗
34. Oyelere A. · Bioconjuagate Chem. · 2007 · 18 · 149010.1021/bc070132i ↗
35. Huang X. · J. Am. Chem. Soc. · 2006 · 128 · 211510.1021/ja057254a ↗
36. Gobin A. · Nano Lett. · 2007 · 7 · 192910.1021/nl070610y ↗
37. Loo C. · Nano Lett. · 2005 · 5 · 70910.1021/nl050127s ↗
38. Gobin A. · Small · 2010 · 6 · 74510.1002/smll.200901557 ↗
39. Ke H. · Angew. Chem. · 2011 · 123 · 307310.1002/ange.201008286 ↗
40. Ji X. · J. Phys. Chem. C · 2007 · 111 · 624510.1021/jp0702245 ↗
41. Jin S. · Cancer Res. · 2011 · 71 · 736010.1158/0008-5472.CAN-11-2023 ↗
42. Bardhan R. · Adv. Funct. Mater. · 2009 · 19 · 390110.1002/adfm.200901235 ↗
43. Chen W. · Nanomedicine · 2014 · 9 · 120910.2217/nnm.13.84 ↗
44. Schwartzberg A. · J. Phys. Chem. B · 2006 · 110 · 1993510.1021/jp062136a ↗
45. Dowgiallo A. · Phys. Chem. Chem. Phys. · 2011 · 13 · 2158510.1039/c1cp22743b ↗
46. Dowgiallo A. · Nano Lett. · 2011 · 11 · 325810.1021/nl201557s ↗
47. Preciado-Flores S. · J. Mater. Chem. · 2011 · 21 · 234410.1039/C0JM03690K ↗
48. Xie H. · Nanoscale · 2013 · 5 · 76510.1039/C2NR33187J ↗
49. Schwartzberg A. · J. Phys. Chem. B · 2004 · 108 · 1919110.1021/jp048430p ↗
50. Schwartzberg A. · Anal. Chem. · 2006 · 78 · 473210.1021/ac060220g ↗
51. Kobayashi Y. · J. Phys. Chem. B · 2003 · 107 · 742010.1021/jp027759c ↗
52. Salgueiriño-Maceira V. · Langmuir · 2006 · 22 · 145510.1021/la0526885 ↗